Literature DB >> 2724437

Bladder hypocompliance in the spinal cord injury population.

R H Hackler1, M K Hall, T A Zampieri.   

Abstract

To determine the incidence and effects of low bladder compliance on the upper urinary tracts in spinal cord injury patients, we evaluated the last 254 patients during a 3-year period who underwent a complete urodynamic study, along with an excretory urogram and/or renal ultrasound. Compliance was determined at 100 cc volume. A compliance number of 20 or less was considered low. Of the 254 patients 43 (17 per cent) had low compliant bladders by our definition. Hydronephrosis was present in 56 of the 84 renal units (64 per cent) and reflux was present in 39 (46 per cent). These results are in sharp contrast to the normal compliant group in which 21 per cent of 418 renal units had hydronephrosis and only 6 per cent had reflux. Of the 254 patients over-all 44 had lower motor neuron lesions as determined by no bulbocavernosus reflex as well as a denervated external sphincter; 22 of these 44 patients (50 per cent) had low compliant bladders. Conversely, among the 210 patients with suprasacral lesions only 21 (10 per cent) had low compliant bladders. In conclusion, the development of a low compliant bladder in spinal cord injury patients is not an uncommon event and places the upper urinary tracts at great risk. All attempts must be directed toward maintaining low detrusor pressures, and these patients must have adequate and frequent followup evaluation.

Entities:  

Mesh:

Year:  1989        PMID: 2724437     DOI: 10.1016/s0022-5347(17)41319-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  Clinical significance of urodynamic study parameters in maintenance of renal function in spinal cord injury patients.

Authors:  Ji Cheol Shin; Youngsang Lee; HeaEun Yang; Dae Hyun Kim
Journal:  Ann Rehabil Med       Date:  2014-06-26

Review 2.  Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury.

Authors:  Mikolaj Przydacz; Piotr Chlosta; Jacques Corcos
Journal:  Int Urol Nephrol       Date:  2018-03-22       Impact factor: 2.370

3.  Complications, secondary interventions and long term morbidity after en bloc sacrectomy.

Authors:  J J Verlaan; J S Kuperus; W B Slooff; A Hennipman; F C Oner
Journal:  Eur Spine J       Date:  2014-12-27       Impact factor: 3.134

4.  Remodeling of extracellular matrix in the urinary bladder of paraplegic rats results in increased compliance and delayed fiber recruitment 16 weeks after spinal cord injury.

Authors:  Tyler G Tuttle; Heidi L Lujan; Nathan R Tykocki; Stephen E DiCarlo; Sara Roccabianca
Journal:  Acta Biomater       Date:  2022-01-13       Impact factor: 8.947

5.  Urodynamic patterns after traumatic spinal cord injury.

Authors:  Mahima Agrawal; Mrinal Joshi
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

6.  Saline volume in transvesical intra-abdominal pressure measurement: enough is enough.

Authors:  J De Waele; P Pletinckx; S Blot; E Hoste
Journal:  Intensive Care Med       Date:  2006-02-14       Impact factor: 17.440

7.  Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: impact on the quality of life of patients with SCI.

Authors:  C Anquetil; S Abdelhamid; A Gelis; C Fattal
Journal:  Spinal Cord       Date:  2016-04-26       Impact factor: 2.772

8.  Study of the electromechanical activity of the urinary bladder. An experimental study.

Authors:  A Shafik
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

9.  International spinal cord injury urodynamic basic data set (version 2.0).

Authors:  Jürgen Pannek; Michael Kennelly; Thomas M Kessler; Todd Linsenmeyer; Jean-Jacques Wyndaele; Fin Biering-Sørensen
Journal:  Spinal Cord Ser Cases       Date:  2018-11-01

10.  An exploratory pathways analysis of temporal changes induced by spinal cord injury in the rat bladder wall: insights on remodeling and inflammation.

Authors:  Silvia Wognum; Claudio E Lagoa; Jiro Nagatomi; Michael S Sacks; Yoram Vodovotz
Journal:  PLoS One       Date:  2009-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.